Sage Therapeutics has been working in the area of steroid-derived compounds that affect CNS receptor signaling.
This not only makes eradication of the virus very difficult but also increases the risk of viral mutation, leading to drug resistance and treatment failure. One of these sites is the CNS.
Benzodiazepines are a class of drugs (commonly referred to as “benzos”) prescribed to treat anxiety, panic disorder, seizures ...
Scientists from the University of Copenhagen say they have developed a drug that decreases appetite while increasing calorie ...
This makes drug development for CNS diseases difficult, as traditional preclinical models are unable to routinely identify molecules that would have a high probability of success in the clinic.
A man who survived two overdoses from drugs allegedly supplied by now-imprisoned former Democratic donor Ed Buck was found ...
HOUSTON, TX / ACCESSWIRE / November 18, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a ...
The Boston biotech's blood-brain barrier-crossing technology and lead Alzheimer's disease drug appear to have been big draws for the Chicago drug giant. Pharma giant AbbVie is building its ...
A broad range of nanomedicines is being developed to improve drug delivery for CNS disorders. The structure of the blood-brain barrier (BBB), the presence of efflux pumps and the expression of ...